Summary of Key Points Core Viewpoint - The company is utilizing idle raised funds for cash management through a bank wealth management product to enhance fund efficiency and returns for shareholders while ensuring it does not affect the ongoing investment projects. Group 1: Investment Overview - The purpose of the entrusted wealth management is to improve the efficiency of fund usage and increase returns for the company and its shareholders [1] - The investment amount for this wealth management is set at 200 million RMB [1] - The source of funds comes from the net proceeds of the initial public offering, which amounted to 244,113.45 million RMB after deducting issuance costs [1][2] Group 2: Investment Details - The company has approved the use of up to 250 million RMB of temporarily idle raised funds for purchasing safe, liquid, and principal-protected investment products [2][4] - The specific wealth management product is a structured deposit with a term of 181 days, linked to the USD/JPY exchange rate [3][4] - The expected annualized return ranges from a minimum of 0.45% to a maximum of 2.13% depending on market conditions [3] Group 3: Financial Impact - The total assets of the company as of the latest quarter are 1,228,443.48 million RMB, with a net asset value of 1,131,212.34 million RMB [5] - The entrusted wealth management amount of 200 million RMB represents 18.89% of the company's cash at the end of the latest reporting period, indicating a manageable impact on the company's financial health [5] - The company has previously engaged in cash management with a total of 60 million RMB invested in various wealth management products over the last 12 months, yielding a return of 491.89 million RMB [7]
甘李药业: 关于使用闲置募集资金进行现金管理的进展公告